X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3126) 3126
Publication (124) 124
Book / eBook (15) 15
Book Review (12) 12
Book Chapter (5) 5
Magazine Article (3) 3
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2984) 2984
male (1920) 1920
female (1593) 1593
middle aged (1307) 1307
adult (1199) 1199
mediastinal neoplasms - secondary (1048) 1048
aged (903) 903
index medicus (847) 847
mediastinal neoplasms - pathology (725) 725
tomography, x-ray computed (646) 646
mediastinal neoplasms - diagnostic imaging (574) 574
surgery (573) 573
lung neoplasms - pathology (538) 538
lymphatic metastasis (527) 527
oncology (503) 503
mediastinal neoplasms - diagnosis (495) 495
mediastinal neoplasms - surgery (495) 495
adolescent (437) 437
neoplasm staging (404) 404
diagnosis, differential (396) 396
respiratory system (393) 393
lung neoplasms - secondary (385) 385
retrospective studies (361) 361
prognosis (334) 334
treatment outcome (333) 333
mediastinum (328) 328
cancer (319) 319
child (300) 300
lung neoplasms - surgery (289) 289
mediastinal neoplasms - complications (287) 287
diagnosis (284) 284
cardiac & cardiovascular systems (282) 282
lung neoplasms - diagnostic imaging (281) 281
radiology, nuclear medicine & medical imaging (276) 276
chemotherapy (274) 274
follow-up studies (263) 263
aged, 80 and over (252) 252
lymph nodes - pathology (250) 250
mediastinal neoplasms - drug therapy (249) 249
antineoplastic combined chemotherapy protocols - therapeutic use (245) 245
tumors (224) 224
combined modality therapy (222) 222
mediastinal neoplasms - therapy (209) 209
lung cancer (204) 204
biopsy (201) 201
radiography (199) 199
metastasis (196) 196
medicine & public health (186) 186
child, preschool (183) 183
survival rate (178) 178
carcinoma, non-small-cell lung - secondary (175) 175
radiotherapy (174) 174
pathology (172) 172
pediatrics (170) 170
lung neoplasms - diagnosis (169) 169
infant (168) 168
mediastinal neoplasms - radiotherapy (168) 168
carcinoma, non-small-cell lung - pathology (164) 164
magnetic resonance imaging (159) 159
care and treatment (158) 158
carcinoma (151) 151
mediastinal neoplasms - mortality (139) 139
young adult (139) 139
fatal outcome (138) 138
adenocarcinoma - secondary (131) 131
immunohistochemistry (128) 128
carcinoma, non-small-cell lung - surgery (126) 126
sensitivity and specificity (125) 125
management (122) 122
lymph node excision (121) 121
abridged index medicus (116) 116
prospective studies (116) 116
hematology (115) 115
medicine, general & internal (115) 115
radionuclide imaging (115) 115
lymphomas (112) 112
mediastinoscopy (111) 111
neoplasm invasiveness (110) 110
positron-emission tomography (108) 108
therapy (108) 108
lung neoplasms - mortality (106) 106
positron-emission-tomography (106) 106
mediastinum - pathology (104) 104
bone neoplasms - secondary (103) 103
survival (103) 103
survival analysis (101) 101
time factors (99) 99
biopsy, needle (97) 97
predictive value of tests (96) 96
radiopharmaceuticals (96) 96
experience (94) 94
neoplasms (94) 94
children (92) 92
testicular neoplasms - pathology (92) 92
fluorodeoxyglucose f18 (91) 91
liver neoplasms - secondary (91) 91
carcinoma, squamous cell - secondary (90) 90
computed-tomography (89) 89
neoplasm metastasis (89) 89
risk factors (89) 89
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2715) 2715
French (87) 87
Japanese (87) 87
German (81) 81
Spanish (51) 51
Russian (49) 49
Polish (24) 24
Italian (21) 21
Chinese (18) 18
Dutch (4) 4
Portuguese (2) 2
Romanian (2) 2
Bulgarian (1) 1
Croatian (1) 1
Czech (1) 1
Finnish (1) 1
Hebrew (1) 1
Hungarian (1) 1
Korean (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Cancer, ISSN 0959-8049, 2017, Volume 76, pp. 1 - 7
Abstract Introduction Treatment options for patients with platinum refractory metastatic germ cell tumours (GCT) relapsing after high-dose chemotherapy and... 
Hematology, Oncology and Palliative Medicine | Germ cell cancer | Immunotherapy | PD-L1 | Checkpoint inhibition | Platinum refractory disease | Testicular cancer | PD-1 | LONG-TERM SURVIVAL | PD-L1 EXPRESSION | TUMORS | ONCOLOGY | NIVOLUMAB | CARCINOMA | Lung Neoplasms - drug therapy | Seminoma - diagnostic imaging | Teratoma | Endodermal Sinus Tumor - drug therapy | Compassionate Use Trials | Choriocarcinoma, Non-gestational - secondary | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Antibodies, Monoclonal - therapeutic use | Male | Tomography, X-Ray Computed | Transplantation, Autologous | Testicular Neoplasms - pathology | Seminoma - metabolism | Stem Cell Transplantation | Mediastinal Neoplasms - drug therapy | Lung Neoplasms - secondary | Adult | Neoplasms, Germ Cell and Embryonal - drug therapy | Retrospective Studies | Choriocarcinoma, Non-gestational - metabolism | Endodermal Sinus Tumor - secondary | Endodermal Sinus Tumor - diagnostic imaging | Ifosfamide - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Seminoma - drug therapy | Testicular Neoplasms - metabolism | Programmed Cell Death 1 Receptor - metabolism | Etoposide - therapeutic use | Neoplasms, Germ Cell and Embryonal - metabolism | Treatment Outcome | Choriocarcinoma, Non-gestational - diagnostic imaging | Endodermal Sinus Tumor - metabolism | Neoplasms, Germ Cell and Embryonal - diagnostic imaging | Cisplatin - therapeutic use | Testicular Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - pathology | Lung Neoplasms - diagnostic imaging | Mediastinal Neoplasms - metabolism | Platinum Compounds - administration & dosage | Seminoma - secondary | Choriocarcinoma, Non-gestational - drug therapy | Neoplasms, Germ Cell and Embryonal - secondary | Viral antibodies | Medical research | Relapse | Chemotherapy | Stem cells | Medicine, Experimental | Antibodies | Transplantation | Metastasis | Diseases | Cancer | Apoptosis | Index Medicus
Journal Article
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 05/2014, Volume 9, Issue 5, pp. 654 - 663
Journal Article
American Journal of Clinical Oncology: Cancer Clinical Trials, ISSN 0277-3732, 08/2015, Volume 38, Issue 4, pp. 364 - 366
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 1/2019, Volume 26, Issue 1, pp. 200 - 208
Journal Article
Lung Cancer, ISSN 0169-5002, 12/2017, Volume 114, pp. 50 - 55
Journal Article
Urology, ISSN 0090-4295, 2012, Volume 79, Issue 5, pp. 1079 - 1084
Objective To compare the survival outcomes of patients with advanced nonseminoma and extraretroperitoneal (ERP) disease observed for a clinical complete... 
Urology | LYMPH-NODE DISSECTION | SURGERY | RESECTION | THORACOTOMY | TESTIS | GERM-CELL TUMORS | RESIDUAL MASSES | UROLOGY & NEPHROLOGY | HISTOLOGY | NONSEMINOMATOUS TESTICULAR CANCER | RETROPERITONEAL | Lymph Node Excision | Lung Neoplasms - drug therapy | Head and Neck Neoplasms - secondary | Mediastinal Neoplasms - secondary | Follow-Up Studies | Humans | Middle Aged | Chorionic Gonadotropin, beta Subunit, Human - blood | Male | Testicular Neoplasms - pathology | Cisplatin - administration & dosage | Neoplasm, Residual | Testicular Neoplasms - surgery | Young Adult | Mediastinal Neoplasms - drug therapy | Lung Neoplasms - secondary | Retroperitoneal Space | Adult | Neoplasms, Germ Cell and Embryonal - drug therapy | Liver Neoplasms - secondary | alpha-Fetoproteins - metabolism | Head and Neck Neoplasms - diagnostic imaging | Head and Neck Neoplasms - drug therapy | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Proportional Hazards Models | Treatment Outcome | Lymphatic Metastasis | Mediastinal Neoplasms - diagnostic imaging | Liver Neoplasms - diagnostic imaging | Disease Progression | Orchiectomy | Biomarkers, Tumor - blood | Neoplasms, Germ Cell and Embryonal - diagnostic imaging | Radiography | Disease-Free Survival | Testicular Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Lung Neoplasms - diagnostic imaging | Neoplasms, Germ Cell and Embryonal - surgery | Neoplasms, Germ Cell and Embryonal - secondary | Chemotherapy | Care and treatment | Cancer
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 07/2011, Volume 6, Issue 7, pp. 1236 - 1241
Surgical resection of residual tumor mass in responders to platinum-based chemotherapy has evolved as the preferred treatment of primary mediastinal... 
Mediastinal Mass | Tumor Markers | Surgery | Germ Cell Tumor | SYSTEM | CLASSIFICATION | CANCER | CHEMOTHERAPY | MODERN THERAPY | ONCOLOGY | RESPIRATORY SYSTEM | ADJUNCTIVE SURGERY | EXPERIENCE | Neoplasm, Residual - pathology | Lung Neoplasms - drug therapy | Follow-Up Studies | Neoplasm, Residual - surgery | Humans | Middle Aged | Bone Neoplasms - secondary | Neoplasm Recurrence, Local - drug therapy | Male | Teratoma - surgery | Neoplasm Recurrence, Local - surgery | Brain Neoplasms - surgery | Neoplasm Recurrence, Local - pathology | Young Adult | Brain Neoplasms - secondary | Mediastinal Neoplasms - drug therapy | Lung Neoplasms - secondary | Time Factors | Adult | Female | Neoplasms, Germ Cell and Embryonal - drug therapy | Retrospective Studies | Bone Neoplasms - drug therapy | Liver Neoplasms - secondary | Mediastinal Neoplasms - surgery | Liver Neoplasms - drug therapy | Liver Neoplasms - surgery | Survival Rate | Treatment Outcome | Bone Neoplasms - surgery | Brain Neoplasms - drug therapy | Teratoma - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - pathology | Teratoma - drug therapy | Adolescent | Neoplasm, Residual - drug therapy | Lung Neoplasms - surgery | Neoplasms, Germ Cell and Embryonal - surgery | Neoplasm Staging | Neoplasms, Germ Cell and Embryonal - pathology | Testicular Neoplasms
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 09/2018, Volume 65, Issue 9, pp. e27229 - n/a
Background Neuroblastoma is one of the most common pediatric solid tumors. Although the 5‐year overall survival rate has increased over the past few decades,... 
neuroblastoma | Galectin‐1 | biomarker | chemotherapy | Galectin-1 | TARGET | CLASSIFICATION | PROLIFERATION | CANCER | INVASION | ONCOLOGY | POOR-PROGNOSIS | DISEASE | PEDIATRICS | HEMATOLOGY | EXPRESSION | PROGRESSION | MICRORNA | Prognosis | Tissue Array Analysis | Humans | Neuroblastoma - blood | Child, Preschool | Infant | Male | Galectin 1 - blood | Immunoenzyme Techniques | Retroperitoneal Neoplasms - chemistry | Mediastinal Neoplasms - drug therapy | Retroperitoneal Neoplasms - drug therapy | Galectin 1 - analysis | Female | Retroperitoneal Neoplasms - blood | Retroperitoneal Neoplasms - pathology | Neuroblastoma - pathology | Mediastinal Neoplasms - blood | Galectin 1 - biosynthesis | Neuroblastoma - chemistry | Enzyme-Linked Immunosorbent Assay | Biomarkers, Tumor - analysis | Neoplasm Proteins - biosynthesis | Kaplan-Meier Estimate | Tumor Burden | Bone Marrow Neoplasms - secondary | Biomarkers, Tumor - blood | Mediastinal Neoplasms - chemistry | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - pathology | Neuroblastoma - drug therapy | Progression-Free Survival | Neoplasm Proteins - analysis | Neoplasm Proteins - blood | Neoplasm Staging | Medical colleges | Chemotherapy | Metastasis | Neuroblastoma | Biological monitoring | Cancer | Therapy | Correlation | Biomonitoring | Histology | Patients | Survival | Metastases | Medical prognosis | Bone marrow | Biomarkers | Solid tumors | Tumors
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 12/2012, Volume 7, Issue 12, pp. 1798 - 1806
Pathologic nodal stage is the key prognostic factor in resectable non–small-cell lung cancer (NSCLC). Mediastinal lymph node (MLN) metastasis connotes a poor... 
Outcome of care | Non–small-cell lung cancer | Surgical resection | Mediastinal lymph nodes | Staging | Quality of care | Non-small-cell lung cancer | FORTHCOMING 7TH EDITION | NUMBER | LONG-TERM SURVIVAL | TNM CLASSIFICATION | RANDOMIZED-TRIAL | SURGEON SPECIALTY | PULMONARY RESECTION | LYMPHADENECTOMY | ONCOLOGY | RESPIRATORY SYSTEM | OUTCOMES | Lymph Node Excision | Mediastinal Neoplasms - secondary | Adenocarcinoma - pathology | Prognosis | Follow-Up Studies | Adenocarcinoma, Bronchiolo-Alveolar - pathology | Lung Neoplasms - mortality | Carcinoma, Large Cell - pathology | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Adenocarcinoma, Bronchiolo-Alveolar - mortality | Carcinoma, Squamous Cell - surgery | Lung Neoplasms - pathology | Male | Mediastinal Neoplasms - mortality | Carcinoma, Large Cell - mortality | Pneumonectomy | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - surgery | Neoplasm Recurrence, Local - pathology | Carcinoma, Squamous Cell - mortality | Female | Mediastinal Neoplasms - surgery | Carcinoma, Non-Small-Cell Lung - pathology | SEER Program | Carcinoma, Non-Small-Cell Lung - surgery | Adenocarcinoma, Bronchiolo-Alveolar - surgery | Risk Factors | Survival Rate | Lymphatic Metastasis | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Large Cell - surgery | Lung Neoplasms - surgery | Aged | Neoplasm Staging | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Cohort Studies
Journal Article